Poltreg S.A. (WSE: PTG)
Poland
· Delayed Price · Currency is PLN
53.60
-0.20 (-0.37%)
Sep 27, 2024, 5:00 PM CET
Poltreg Company Description
Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases.
It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis.
The company was incorporated in 2016 and is based in Gdansk, Poland.
Poltreg S.A.
Country | Poland |
Founded | 2016 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 26 |
CEO | Piotr Trzonkowsk |
Contact Details
Address: Waly Piastowskie 1 lok. 1508 Gdansk, 80-855 Poland | |
Phone | 48 512 53 24 01 |
Website | poltreg.tech |
Stock Details
Ticker Symbol | PTG |
Exchange | Warsaw Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | PLN |
ISIN Number | PLPLTRG00038 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Piotr Trzonkowsk | Chief Executive Officer |
Kamilla Bok | Chief Operating Officer |